• Home
  • NEW DAY MEDICINE
  • 5 (67) 2024
  • 37 -5 (67) 2024 - Abdieva R.M. - LIFESTYLE CORRECTION OF PATIENTS WITH CIRRHOSIS OF LIVER VIRAL HBV, HDV, HCV ETIOLOGY IN UZBEKISTAN

37 -5 (67) 2024 - Abdieva R.M. - LIFESTYLE CORRECTION OF PATIENTS WITH CIRRHOSIS OF LIVER VIRAL HBV, HDV, HCV ETIOLOGY IN UZBEKISTAN

LIFESTYLE CORRECTION OF PATIENTS WITH CIRRHOSIS OF LIVER VIRAL HBV, HDV, HCV ETIOLOGY IN UZBEKISTAN

Abdieva R.M. - RSSPMCEMPD Research Institute of Virology, Tashkent.

Resume

The national cuisine of Uzbekistan is diverse, high-calorie and nutritious. Therefore, it is necessary not to restrict patients in foodstuffs, but to adapt their consumption in accordance with their general condition. Stimulate physical activity, taking into account the interests of patients and their capabilities. Sarcopenia is considered a hot topic in clinical hepatology, and a comprehensive review of skeletal muscle loss in individuals chronically infected with HBV or HCV, regardless of the stage of liver disease, will reinforce an integrated approach to medicine, nutrition and physical education in the daily clinical care of HBV and HCV patients.

Keywords: sarcopenia in liver cirrhosis, occurrence of sarcopenia, nutrition in liver cirrhosis.

First page

215

Last page

219

For citation: Abdieva R.M. - LIFESTYLE CORRECTION OF PATIENTS WITH CIRRHOSIS OF LIVER VIRAL HBV, HDV, HCV ETIOLOGY IN UZBEKISTAN//New Day in Medicine 5(67)2024 215-219 https://newdayworldmedicine.com/en/article/3758

List of References

  1. Journal of gepatology 2018 EASL Clinical Practice Guidelines on nutrition in chronic liver disease
  2. Maillette de Buy Wenniger L, Beuers U. Bile salts and cholestasis. Dig Liver Dis 2010; 409‐418. https://doi.org/10.1016/j.dld.2010.03.015.
  3. Marta Paula Pereira Coelho, Pedro Alves Soares Vaz de Castro, Thaís Pontello de Vries, Enrico Antônio Colosimo, Juliana Maria Trindade Bezerra, Gifone Aguiar Rocha, and Luciana Diniz Silva. Sarcopenia in chronic viral hepatitis: From concept to clinical relevance. World J Hepatol. 2023 May 27; 15(5): 649–665. Published online 2023 May 27. doi: 10.4254/wjh.v15.i5.649 PMCID: PMC10251280 PMID: 37305369
  4. Montanari A, Simoni I, Vallisa D, Trifirò A, Colla R, Abbiati R, et al. Free amino acids in plasma and skeletal muscle of patients with liver cirrhosis. Hepatology 1988; 1034‐1039. https://doi.org/10.1002/hep.1840080509.
  5. Mullen KD, Denne SC, McCullough AJ, Savin SM, Bruno D, Tavill AS, et al. Leucine metabolism in stable cirrhosis. Hepatology 1986; 622‐630. https://doi.org/10.1002/hep.1840060412.
  6. Shalimar, Sheikh MF, Mookerjee RP, Agarwal B, Acharya SK, Jalan R. Prognostic role of ammonia in patients with cirrhosis. Hepatology 2019; 982‐994. https://doi.org/10.1002/hep.30534
  7. Shawcross DL, Wright GAK, Stadlbauer V, Hodges SJ, Davies NA, Wheeler‐Jones C, et al. Ammonia impairs neutrophil phagocytic function in liver disease. Hepatology 2008; 1202‐1212. https://doi.org/10.1002/hep.22474.
  8. Yamato M, Muto Y, Yoshida T, Kato M, Moriwaki H. Clearance rate of plasma branched‐chain amino acids correlates significantly with blood ammonia level in patients with liver cirrhosis. Int Hepatol Commun 1995; 91‐96. https://doi.org/10.1016/0928‐4346(94)00159‐3.

    file

    download